Aurobindo Pharma has reported profit after tax of Rs 188.6 crore for the quarter ended December 2010, up 10% as compared to Rs 172 crore in same period the previous year.
Revenues went up by 30.3% to Rs 1,192 crore from Rs 915 crore (YoY). Operating profit margin was flat at 26.8% versus 26.5%.
The company has received forex gain of Rs 4.08 crore as against Rs 24.81 crore on year-on-year basis.
Interest costs declined at Rs 11.46 crore from Rs 12.66 crore.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment